burning mouth syndrome (BMS)
Conditions
Interventions
Experimental group:Taking methylcobalamin tablets and Chinese patent medicine Zhongtong'an
Control group:Taking methylcobalamin tablets and a placebo
Sponsors
Affiliated Stomatological Hospital of Southwest Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as BMS patients (visual analogue scale (VAS) value >=4) according to the medical history and clinical examination; 2. Aged 18-60 years; 3. Blood routine, liver and kidney function, and fasting blood sugar are basically normal; 4. The patient did not receive other drug treatment other than the regimen during treatment; 5. Patients participate voluntarily, sign informed consent and provide personal medical history, can participate in the trial on time and can complete the entire research steps, and can come to the hospital for regular follow-up visits as required and strictly follow the doctor's orders.
Exclusion criteria
Exclusion criteria: 1. Suffering from other confirmed oral mucosal diseases or periodontitis; 2. Patients during pregnancy and childbearing age; 3. Patients with severe systemic diseases (such as diabetes, osteoporosis, gastrointestinal bleeding) or tumors; 4. Patients with allergies or a history of drug allergies; 5. Those with a history of smoking, alcoholism, drug abuse, or drug addiction; 6. Diagnosed with mental illness; 7. Those who have participated in or are participating in other clinical trials within 1 month before screening.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| numbness;quality of life;depression situation; | — |
Countries
China
Contacts
Public ContactSun Chen
Affiliated Stomatological Hospital of Southwest Medical University
Outcome results
None listed